Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Fatal Case of Candidemia due to Candida glabrata.

Giri S, Kindo AJ, Kalyani J.

J Lab Physicians. 2014 Jan;6(1):63-4. doi: 10.4103/0974-2727.129098. No abstract available.

2.

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.

Bodey GP, Mardani M, Hanna HA, Boktour M, Abbas J, Girgawy E, Hachem RY, Kontoyiannis DP, Raad II.

Am J Med. 2002 Apr 1;112(5):380-5.

PMID:
11904112
3.

Is the incidence of candidemia caused by Candida glabrata increasing in Brazil? Five-year surveillance of Candida bloodstream infection in a university reference hospital in southeast Brazil.

Moretti ML, Trabasso P, Lyra L, Fagnani R, Resende MR, de Oliveira Cardoso LG, Schreiber AZ.

Med Mycol. 2013 Apr;51(3):225-30. doi: 10.3109/13693786.2012.708107. Epub 2012 Aug 27.

PMID:
22920712
4.

Candida glabrata: an emerging pathogen in Brazilian tertiary care hospitals.

Colombo AL, Garnica M, Aranha Camargo LF, Da Cunha CA, Bandeira AC, Borghi D, Campos T, Senna AL, Valias Didier ME, Dias VC, Nucci M.

Med Mycol. 2013 Jan;51(1):38-44. doi: 10.3109/13693786.2012.698024. Epub 2012 Jul 5.

PMID:
22762208
5.

The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.

Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I.

Cancer. 2008 Jun;112(11):2493-9. doi: 10.1002/cncr.23466.

6.

Recurrent episodes of candidemia due to Candida glabrata with a mutation in hot spot 1 of the FKS2 gene developed after prolonged therapy with caspofungin.

Durán-Valle MT, Gago S, Gómez-López A, Cuenca-Estrella M, Jiménez Díez-Canseco L, Gómez-Garcés JL, Zaragoza O.

Antimicrob Agents Chemother. 2012 Jun;56(6):3417-9. doi: 10.1128/AAC.06100-11. Epub 2012 Mar 5.

7.

Species identification and antifungal susceptibility testing of Candida bloodstream isolates from population-based surveillance studies in two U.S. cities from 2008 to 2011.

Lockhart SR, Iqbal N, Cleveland AA, Farley MM, Harrison LH, Bolden CB, Baughman W, Stein B, Hollick R, Park BJ, Chiller T.

J Clin Microbiol. 2012 Nov;50(11):3435-42. doi: 10.1128/JCM.01283-12. Epub 2012 Aug 8.

8.

Candida glabrata sepsis associated with chorioamnionitis in an in vitro fertilization pregnancy: case report and review.

Jackel D, Lai K.

Clin Infect Dis. 2013 Feb;56(4):555-8. doi: 10.1093/cid/cis936. Epub 2012 Nov 9.

9.

Evaluation of species distribution and risk factors of candidemia: a multicenter case-control study.

Yapar N, Pullukcu H, Avkan-Oguz V, Sayin-Kutlu S, Ertugrul B, Sacar S, Cetin B, Kaya O.

Med Mycol. 2011 Jan;49(1):26-31. doi: 10.3109/13693786.2010.501344. Epub 2010 Jul 22.

PMID:
20662635
10.

Neonatal Candida glabrata sepsis: clinical and laboratory features compared with other Candida species.

Fairchild KD, Tomkoria S, Sharp EC, Mena FV.

Pediatr Infect Dis J. 2002 Jan;21(1):39-43.

PMID:
11791097
11.

Candidemia in nonneutropenic critically ill patients: risk factors for non-albicans Candida spp.

Playford EG, Marriott D, Nguyen Q, Chen S, Ellis D, Slavin M, Sorrell TC.

Crit Care Med. 2008 Jul;36(7):2034-9. doi: 10.1097/CCM.0b013e3181760f42.

PMID:
18552700
12.

Analysis of Candida glabrata strains with reduced sensitivity to micafungin in vitro isolated from a patient with persistent Candidemia.

Ishikawa T, Takata T, Akamatsu S, Hatakenaka K, Matsumoto S, Maki K, Ikeda F, Tamai R, Tamura K.

Jpn J Infect Dis. 2010 Sep;63(5):332-7.

13.

A probable case of aspiration pneumonia caused by Candida glabrata in a non-neutropenic patient with candidemia.

Kobayashi T, Miyazaki Y, Yanagihara K, Kakeya H, Ohno H, Higashiyama Y, Hirakata Y, Mizuta Y, Tomono K, Tashiro T, Kohno S.

Intern Med. 2005 Nov;44(11):1191-4.

14.

Fatal Postoperative Candida glabrata Septicemia in a Child with Congenital Heart Disease.

Baradkar V, Taklikar S, Kumar S.

J Glob Infect Dis. 2009 Jan;1(1):68-70. doi: 10.4103/0974-777X.52986.

15.

Time to positivity of blood culture can predict different Candida species instead of pathogen concentration in candidemia.

Huang L, Zhang YY, Sun LY.

Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):917-22. doi: 10.1007/s10096-013-1826-8. Epub 2013 Feb 1.

PMID:
23370971
16.

A scoring model of factors associated with Candida glabrata candidemia among critically ill patients.

Tapia GG, Razonable RR, Eckel-Passow JE, Lahr BD, Afessa B, Keegan MT, Catania J, Baddour LM.

Mycoses. 2012 May;55(3):228-36. doi: 10.1111/j.1439-0507.2011.02069.x. Epub 2011 Jul 21.

PMID:
21777296
17.

Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.

Forrest GN, Weekes E, Johnson JK.

J Infect. 2008 Feb;56(2):126-9. Epub 2007 Dec 21.

PMID:
18082269
18.

Differences in patient risk factors and source of candidaemia caused by Candida albicans and Candida glabrata.

Segireddy M, Johnson LB, Szpunar SM, Khatib R.

Mycoses. 2011 Jul;54(4):e39-43. doi: 10.1111/j.1439-0507.2009.01824.x. Epub 2009 Dec 28.

PMID:
20051013
19.

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.

Fraser VJ, Jones M, Dunkel J, Storfer S, Medoff G, Dunagan WC.

Clin Infect Dis. 1992 Sep;15(3):414-21. Review.

PMID:
1520786
20.

Prevalence of Candida bracarensis and Candida nivariensis in a Spanish collection of yeasts: comparison of results from a reference centre and from a population-based surveillance study of candidemia.

Cuenca-Estrella M, Gomez-Lopez A, Isla G, Rodriguez D, Almirante B, Pahissa A, Rodriguez-Tudela JL; Barcelona Candidemia Project Study Group.

Med Mycol. 2011 Jul;49(5):525-9. doi: 10.3109/13693786.2010.546373. Epub 2011 Jan 3.

PMID:
21198347
Items per page

Supplemental Content

Write to the Help Desk